Table 1.
CHARACTERISTICS OF CNSD USERS (n = 100) | |
Gender | |
Men | 34 (34%) |
Women | 66 (66%) |
Age, year | |
Mean (SD) | 78.5 (6.5) |
Median (range) | 79 (66–90) |
Age groups | |
65–74 | 28 (28%) |
75–84 | 51 (51%) |
≥ 85 | 21 (21%) |
FREQUENCY OF MEDICATION USE (non-mutually exclusive) | |
Benzodiazepines | 20 (15%) |
Opioid analgesics | 45 (34%) |
Z-hypnotics | 68 (51%) |
USE PATTERNS | |
Benzodiazepines | 7 (7%) |
Opioid analgesics | 21 (21%) |
Z-hypnotics | 42 (42%) |
Opioid analgesics + Benzodiazepine | 4 (4%) |
Opioid analgesics + Z-hypnotics | 17 (17%) |
Benzodiazepines + Z-hypnotics + Opioid analgesics | 2 (2%) |
SDS SCORE Mean (SD) / Median (range) | |
CNSDs | 4.2 (3.3) / 4.0 (0–12) |
Benzodiazepines | 3.5 (3.1) / 3.5 (0–10) |
Opioid analgesics | 4.1 (3.3) / 3.0 (0–12) |
Z-hypnotics | 4.4 (3.3) / 4.0 (0–12) |